Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
United States
University of California San Francisco (UCSF), San Francisco, California Massachusetts General Hospital, Boston, Massachusetts The Ohio State University, Columbus, Ohio The University of Texas MD Anderson Cancer Center, Houston, Texas